Introduction
In neonates, brain damage is most often associated with perinatal asphyxia (PA), which occurs in approximately 1-6 per 1000 live full-term births [1, 2] . PA may result in neonatal mortality, or depending on its severity, hypoxic-ischemic encephalopathy (HIE) may develop, which results in longlasting neurodevelopmental motor and cognitive dysfunctions in approximately 25% of survivors [3] . Cyclooxygenases (COXs) are the rate-limiting enzymes that catalyze the conversion of arachidonic acid released from membrane phospholipids by phospholipase-A 2 to prostaglandin (PG)-H 2 , which is further converted to biologically active prostaglandins, including PGD 2 , PGE 2 , PGF , PGI 2 and thromboxane A 2 [4] . The two COX isozymes, COX-1 and COX-2, have similar catalytic activities but differ in their pharmacological properties and tissue distributions [5] . Although COX-1 and COX-2 are both constitutively expressed in the central nervous system [6] , COX-2 is enriched in the hippocampus and the cerebral cortex [7] . Furthermore, COX-2 is the dominant isoform in the newborn brain [8] , providing up to 80% of the total brain COX activity [9] . In the central nervous system, prostanoids modulate synaptic transmission and neurovascular coupling [10, 11] . Neuronal COX-2 plays an essential role in the modulation of excitatory glutamatergic synaptic transmission and long-term synaptic plasticity [10] . Simultaneously, COX-2-derived prostanoids also participate in flow-metabowhisker stimulation in the barrel cortex [12] . Expression of the inducible COX-2 isoform is well-known to be upregulated by various deleterious stimuli including brain trauma [13, 14] , cerebral ischemia [15, 16] [17] . The neuronal induction of COX-2 suggests the enzyme's participation et al diseases, traumatic brain injury, and ischemia-induced neuronal damage and epileptogenesis [18] . COX-2 has an established role in the pathogenesis of HIE. For instance, a previous study showed that administration of COX-2 inhibitors before as well as soon after ischemic insult provided neuronal protection in a rat HIE model [19] . Furthermore, brain ischemia has been associated with high neuronal COX-2 levels also in the neonatal human brain in an autopsy study [20] . Therefore, the role of COX-2 in the mechanism of hypoxic-ischemic neuronal injury could perhaps be best studied in a translational large animal model that could also be used to establish possible neuroprotective treatments.
The newborn pig is an accepted large animal model for the human neonate, as brain size, gyrencephalic structure, neurodevelopmental state of the brain and cerebral metabolism at birth are similar in both species [21] . COX-2 has been quite as the major constitutive isoform in this species [8] . According to immunohistochemistry analysis, COX-2 expression in the brain and cerebral arteries of newborn piglets is markedly induced by global cerebral ischemia [15, 16] but, confoundingly, not by asphyxia [16, 22] . In these studies, global cerebral ischemia was induced by raising the intracranial pressure above the arterial pressure for 10 min while venous blood was withdrawn to control the blood pressure and asphyxia was induced by suspending ventilation for 10 min. The translaof neuronal COX-2 induction in neuronal damage during HIE development has thus become difficult to determine, as the clinical presentation of HIE is associated with asphyxia and not global no-flow ischemia. Furthermore, animals in these studies survived only 4-8 h, so it was also possible that the expression changes after asphyxia would have occurred at a later and thus undetected time point.
In recent years, we established and published two piglet PA/HIE models of increasing severity [22, 23] to assess the neuroprotective effect of inhaled molecular hydrogen (H 2 ) [23, 24] that was first reported by Ohsawa et al in an adult rat stroke model [25] . H 2 was described as a neuroprotective agent that penetrates the blood-brain barrier and selectively reduces cytotoxic hydroxyl radicals [25] . H 2 was also found to be effective in rodent HIE models [26, 27] and in various other neuropathological conditions, such as Parkinson's disease [28] , auditory neuropathy [29] and even stress-induced learning impairment [30] . The mechanistic details of H 2 -induced neuroprotection are still unclear but likely involve inhibition of oxidative injury and inhibition of neuroinflammation [31] . However, we have virtually no information on the mechanism of H 2 -induced neuroprotection in PA/HIE, let alone in a large animal model. Therefore, the major purpose of the present study was to determine the effect of H 2 on asphyxia-induced neuronal COX-2 expression correlated with 8'-hydroxy-2'-deoxyguanozine [23] (8-OHdG) and Iba-1 immunohistochemistry markers of oxidative stress and neuroinflammation, respectively, in our translational PA/HIE piglet model.
Materials and methods
To study neuronal COX-2 expression, we used brain samples of newborn male Large-White piglets (age < 24 h at beginning of experiments, body weight: 1.5-2.5 kg, n=59), which were obtained mainly from previously published studies [23, 32] . In both studies, the anesthetized, artificially ventilated animals were divided into 3-3 experimental groups (n=7-7) including a normoxic time control group ventilated with room air, an asphyxiated group reventilated with room air for 24 h, and an asphyxiated group reventilated with room air containing 2.1% H 2 for 4 h followed by room air for the remaining (20 h) survival time. The major difference between the two previously published studies [23, 32] was the induction method and the duration of asphyxia. Asphyxia was elicited by 8 min of and by 20 min of ventilation with a hypoxic-hypercapnic gas mixture (6% O 2 , 20% CO 2 ) in the second study. Our preliminary results suggested that the length of anesthesia per se in the absence of asphyxia might have affected COX-2 expression, therefore we included an additional naïve control group to study baseline neuronal COX-2 expression. Furthermore, we also used brain samples from normoxic time control animals with 4 h survival from another previous study [24] . In the new naïve control group, piglets (n =5) were anesthetized with sodium thiopental (45 mg/kg, ip; Sandoz, Kundl, Austria), and the brains were immediately perfused with 100 mL cold physiological saline solution through the catheterized common carotid arteries and harvested for immunohistochemical analysis. All procedures were approved by the Animal Care and Use Committee of the University of Szeged. The brain tissues were immersion-fixed with 4% paraformaldehyde at 4 °C for 2 weeks. Paraffin-embedded, 4-μm sections were produced using a microtome (Leica Microsystems, Wetzlar, Germany) and mounted on sylanized slides. Hematoxylineosin staining was performed to assess the extent of neuronal lesions, which was determined by cell counting in most areas. In the cerebral cortex, however, neuropathology scores were determined (0-9) as described previously [23] observers. In each field of view, the neuronal lesions were described as none, scattered, grouped/laminar or panlaminar. The neuropathology score was determined by the incidence of the most severe lesion observed. If the most severe lesions represented less than 20% of the total lesions, the scores were 1, 4, or 7; if 20%-50%, 2, 6, or 8; and if more than 50%, 3, 6, or 9. Thus, higher scores represented increasingly severe neuronal damage.
COX-2 immunohistochemistry was performed using the LEICA BOND-MAX automated immunostainer (Leica Microsystems, Wetzlar, Germany). The slides were dewaxed at 72 °C, and antigen retrieval was performed at pH 6. The slides were then incubated with a rabbit monoclonal antibody against COX-2 diluted at 1:100 (clone SP21, Labvision, Fremont, California, USA) for 30 min followed by horseradish peroxidase-conjugated anti-rabbit antibody (EnVision®; Dako, Glostrup, Denmark). 3,3'-Diaminobenzidine (DAB) tetrahydrochloride solution was used for visualization, and the slides were then counterstained with hematoxylin to visualize the cell nuclei. The slides were dehydrated in an ascending alcohol series, cleared in xylene, covered with a coverslip, scanned in a slide scanner (Pannoramic MIDI, 3DHISTECH Ltd, Budapest, Hungary) and visualized on a personal computer using the Pannoramic Viewer software (3DHISTECH Ltd) at 20x photomicrographs were acquired from each region observed, including 10-10 images of the frontal, temporal, parietal and dentate gyrus of the hippocampus; 10-10 images of the thalamus and the basal ganglia; and 15 images of the cerebellar cortex for the study of Purkinje-cells. The cells were manually counted by two independent observers using ImageJ software (Wayne Rasband, NIH, Bethesda, Maryland, USA).
COX-2-immunopositive neurons relative to all neurons was determined, and the averages/cerebral areas/animals were counted and plotted on box plots using R 3.3.1 software (The R Foundation for Statistical Computing, Vienna, Austria). For statistical analysis, ANOVA on ranks followed by the StudentNewman-Keuls post hoc test was performed using SigmaPlot 12.0 (Systat Software Inc., Chicago, Illinois, USA). P<0.05 was -nopositive neurons was correlated with the previously determined histopathological score [23] , and the result was plotted on a dot plot using R 3.3.1 software.
Based on the results of our COX-2 studies, the parietal cortex was selected for further studies. Tissue microarrays -bedded tissue blocks of the second study (including the time control, 20 min asphyxia, and 20 min asphyxia+H 2 groups) using a custom-made stainless steel tissue puncher (3 mm).
sylanized slides and processed for immunohistochemistry. To determine the extent of oxidative damage in the neurons, 8-OHdG immunohistochemistry was performed [23] . The slides were incubated with a mouse monoclonal primary antibody against 8-OHdG diluted at 1:200 (JaICA Inc, Fukuroi, Japan) for 20 min, followed by incubation with a horseradish peroxidase-conjugated rabbit anti-mouse secondary antibody for 15 min (n=6-6-6). Iba-1 immunohistochemistry was performed to assess microglial activation (n=7-6-6). Slides were incubated with rabbit anti-Iba-1 antibody (Wako Chemicals GmbH, Neuss, Germany) for 30 min, followed by horseradish peroxidase-conjugated anti-rabbit antibody (EnVision®; Dako, Glostrup, Denmark) for 15 min. In both cases, 3,3'-diaminobenzidine was used to visualize the immunostaining, and the slides were then counterstained with hematoxylin to visualize the cell nuclei. The slides were covered with coverslips, scanned in the slide scanner, and visualized on a personal computer using the Pannoramic Viewer software at x40 magnification. Homogeneous, strong nuclear 8-OHdG immunoreactivity indicated oxidative damage. The ratio of these nuclei to the total neuronal nuclei was determined using ImageJ software, similarly to the previously described method. The average/sample was plotted on box plots. The groups were compared with one-way ANOVA on ranks followed by the Student-Newman-Keuls post hoc test (P<0.05). Microglial acti--cation index (RI) [33] . We applied a 0.20 mm×0.25 mm grid to the microphotographs of 3 randomly selected areas/sample in the grid were counted as well as the microglial branches -ned according to the following equation: RI=B 2 /CBD. The and the groups were compared with one-way ANOVA on ranks followed by Dunn's post hoc test (P=0.015). Correlations were plotted and tested using R 3.3.1 software (Pearson's correlation, P<0.05).
Results
Neuronal COX-2 expression in the time controls Neuronal COX-2 expression in the naïve animals was similar to our previous observations and showed marked regional differences: the highest percentages of COX-2-positive neurons were observed in the frontal and parietal cortices as described previously [22] . However, this regional expression pattern appeared markedly changed in the 24-h time controls, -cal regions compared with the naïve or 4-h survival animals ( Figure 1 ). This reduction was found to be limited to the cortex, as the ratio of COX-2-immunopositive neurons remained unchanged in the hippocampus (Figure 1 ).
Effect of asphyxia on neuronal COX-2 expression
In the brain regions obtained from the study of animals exposed to 8-min asphyxia, there was no significant alteration in neuronal COX-2 expression (Figure 2 ), as no difference was noted between the time control and asphyxiated groups in any of the observed regions (Figure 2 ). In contrast, 20-min asphyxia elicited significant increases in neuronal COX-2 immunopositivity in the parietal and occipital cortices, as well as in the hippocampal CA3 region (Figure 2) . Furthermore, the asphyxia-induced elevation of COX-2-immunopositive neurons was also observed in the frontal and temporal cortices and the basal ganglia, although these changes did not reach statistical significance in these regions (Figure 2 ). In the H 2 -treated group, despite exposure to the same level of asphyxia, the ratio of COX-2-immunopositive cells was similar to that in the time control group (Figure 2) . Notably, strong COX-2-immunopositive areas were only recorded in the hippocampal CA1 region and the dentate gyrus displayed low percentages of COX-2-immunopositive neurons in the time controls. In addition, the ratio of immunopositive neurons was unchanged by asphyxia, as these percentages were similar among all three groups. In a similar fashion, COX-2 was pres- 
Assessment of correlation between neuronal COX-2 expression and neuronal damage
As neuronal COX-2 expression was affected by 20-min asphyxia exposure only, we performed all subsequent studies on these animals. We first investigated whether the ratio of COX-2-immunopositive neurons correlated with the previously determined neuropathology scores [23] with higher scores 4). We found no correlation between the neuropathology scores and neuronal COX-2 expression (r=0.38; P<0.01); how--pathology scores were always associated with low-moderate levels of neuronal COX-2 expression, and high neuropathology scores were associated either with high or with low COX-2 expression levels. Notably, low neuropathology score never coincided with high COX-2 expression levels (Figure 4) . Assessment of the correlation between neuronal COX-2 expression and oxidative DNA damage the ratio of 8-OHdG-immunopositive neuronal nuclei ( Figure  5A ) compared with both the time control and the H 2 -treated asphyxia group, indicating the oxidative stress induced by asphyxia and the mitigating effect of molecular H 2 ( Figure  5B ). By assessing the correlation between the ratios of COX-2-and 8-OHdG-immunopositive neurons ( Figure 5C ), we found a marked tendency towards a positive correlation (r=0.71), considering data either from all groups or from the 20-min asphyxia group alone.
Assessment of the correlation between neuronal COX-2 expression and microglial activation
The Iba-1 immunohistochemistry results revealed the distribution of microglia in the parietal cortex ( Figure 6A ). Microglial activation is associated with reduced branching and the adoplower in the group subjected to 20-min asphyxia than in the time control group ( Figure 6B ). However, there was no significant difference between the time controls and the H 2 -treated asphyxiated animals. When all data points were considered, the RI showed no correlation with neuronal COX-2 expression (r=-0.56, Figure 6C ), but when data from only the 20-min lation (r=-0.75) was observed.
Discussion
The major findings of the present study are as follows: 1) neuronal COX-2 expression in the neocortical areas is greatly reduced in 24-h anesthetized time controls; 2) 20-min, but not 8-min, asphyxia exposure elevates the number of COX-2-positive neurons both in the cortex and the hippocampal CA3 sub--campal structures; 3) the effect of asphyxia on neuronal COX-2 abundance is associated and correlated with oxidative stress and microglial activation as shown by enhanced 8-OHdG staining and reduced RI, respectively; and 4) post-asphyxia administration of neuroprotective molecular H 2 prevents the upregulation of neuronal COX-2 expression in all sensitive brain regions with simultaneous reductions in oxidative stress and prevention of microglial activation.
This study is the first to describe the induction of neuronal COX-2 expression following asphyxia in a translational subacute piglet PA/HIE model. In our previous study [23] , we extensively characterized the effect of 20-min asphyxia elicited in newborn (<1 day old) piglets by ventilation with a hypoxichypercapnic (6% O 2 , 20% CO 2 ) gas mixture on hemodynamics, blood gases, metabolites, electroencephalogram and neuropathology. The applied insult resulted in alterations that matched both human pathology and naturally occurring birth asphyxia in swine [34] and corresponded to moderate to severe HIE in all of the animals. Our present results elucidated the confounding results from previous studies in which elevations in COX-2 levels were reported after 10 min of global cerebral ischemia but not 10 min of asphyxia [16] . Our current results suggest that this reported difference was due to the more severe hypoxic/ischemic insult elicited by global cerebral ischemia, and in the present study, the longer asphyxia duration rather than the shorter treatment elicited conditions similar to those observed with global ischemia, which resulted in the upregulation of COX-2.
In the present study, neuronal COX-2 abundance was conspicuously reduced in all neocortical areas of the 24-h time control animals compared with the values previously reported in our 4-h survival study [22] . This difference cannot be attributed to differences in methodology such as for COX-2 immunostaining or cell counting, as the values obtained from the naïve animals in the present study yielded virtually identical data to the previously published values. The decreased number of COX-2-expressing neurons may be in part explained by the inactivation of cortex due to anesthesia, as COX-2 expression is stimulated by neuronal activity [35] . The applied anesthetic/analgesic drugs could exert an inhibitory effect on COX-2 expression by interacting with the nuclear transcriptranscriptional regulator of COX-2 [36] . Although morphine has been reported to have ambiguous stimulatory and inhibi- [37, 38] , midazolam is unequivo- [39] . The applied anesthetic regimen was chosen to enhance the translational potential of our animal model, as morphine/midazolam analgesia/sedation is routinely used in the management of human neonates affected by PA/HIE [40] . Furthermore, experimental data suggested that morphine analgesia may be an important permissive factor by allowing neuroprotective therapies such as therapeutic hypothermia to be effective; mild hypothermia failed to exhibit neuroprotection in the absence of anesthesia and analgesia in newborn pigs [41] . Our current results sugeffect on neuronal survival in part through the attenuation of COX-2 expression. Our findings also suggested a timedependent role of COX-2-derived ROS and prostanoids in the pathomechanism of HIE development in different brain regions, as COX-2 activity-dependent neuronal injury in the early reventilation/reoxygenation phase will be most likely pronounced in regions with high baseline COX-2 expression (especially the frontoparietal neocortex). However, in the delayed secondary energy failure phase, COX-2 will likely remain a more important pathogenic factor for neuronal injury in those areas where the asphyxia-induced elevation dominates the anesthesia -induced depression of COX-2 levels. The present data thus suggested that at least in the neocortical areas, two factors affect neuronal COX-2 abundance. Longterm anesthesia tends to decrease the enzyme levels, whereas asphyxia elevates them. Both the increase in COX-2 levels and the increase in the level of neuronal injury were variable in the piglets subjected to asphyxia, in accordance with the spectrum of human HIE severity. We found that very high percentages of COX-2-immunopositive neurons were inevitably accompanied by the most severe types of cortical neuronal damage. In some cases, however, similarly high neuropathology scores coincided with rather low COX-2 immunopositivity. These areas may perhaps represent those severely damaged areas where the hypoxia/ischemia-induced translational blockade might have prevented the expression of COX-2. Thus, the areas displaying very high neuronal COX-2 levels may represent those areas that were still able after asphyxia to translate new proteins, and the deleterious effects of COX-2 may have contributed most in these areas to the observed neuronal damage.
In the present study, we assessed the effect of a neuroprotective (2.1%) concentration of H 2 on neuronal COX-2 expression. In addition to our previous studies [22] [23] [24] , this concentration was found to be neuroprotective in a number of other disease models as well [25, 42, 43] . Inhaled H 2 can easily penetrate into the brain, as has been shown numerous times by the successful application of the so-called H 2 -clearance technique to quantitatively determine cerebral blood flow in newborn pigs [44] [45] [46] . After rapid equilibration with the blood, the applied H 2 concentration likely resulted in approximately 10-20 μmol/L H 2 brain levels, as determined in both rats and humans [25, 47] . Our current results concerning the correlation of nuclear 8-OHdG immunoreactivity with COX-2 expression and the remarkable 2 inhalation to attenuate elevations in both 8-OHdG and COX-2 levels after asphyxia suggest a role for ROS in the mechanism of COX-2 expression. 8-OHdG is used as a biomarker of oxidative modifications to DNA [48] [49] [50] and is one of the most studied catabolites. Guanine is the best electron donor that has the lowest oxidation potential among the DNA bases [49, 51] . 8-Hydroxylation in the guanine base occurs after an attack by hydroxyl radicals under oxidative stress [52] . Thus, elevations in the number of 8-OHdG-positive by hydroxyl radicals. Importantly, molecular H 2 was originally described as a selective hydroxyl radical scavenger [25] , 2 to attenuate elevations in 8-OHdG levels after asphyxia further confirms the presence of significant oxidative stress perhaps characterized by significant production of hydroxyl radicals in our present PA/HIE piglet model. The connection between this oxidative stress and the observed induction of COX-2 expression may be the activation by ROS and inhibited by antioxidants [53] . The general physiocell growth, cellular stress responses and intracellular signaling [54] ronal development, inflammation and neurodegeneration [55] . [56] . The [36] , and therefore the asphyxia-induced increase in neuronal COX-2 expression is H 2 -treated rat pups, which lends experimental support to our hypothesis [57] . Our results with Iba-1 immunohistochemistry that was used to visualize microglia to determine the RI as an indicator of microglial activation are also in favor of the above-mentioned mechanism. We found that microglia were activated by asphyxia only but not by asphyxia followed by H 2 . As microglial activation has also been reported to be [58] , hydroxyl radicals may the present study.
2 to prevent increases in COX-2 levels after asphyxia suggest that the ROS responsible for triggering COX-2 induction were produced during the early reventilation/reoxygenation phase, as H 2 was administered ROS may arise at later time points as well, for instance from mitochondria during the secondary energy failure [59] , from COX activity itself [60] , or from the activated microglia [61] .
Conclusion
In our translational HIE model, PA-induced increases in neuronal COX-2 expression were dependent on regional vulnerability and on the severity of asphyxia. ROS are known to trigger COX-2 expression, and in turn, COX-2 activity is also an et al Acta Pharmacologica Sinica important source of ROS after PA [22, 62] . One of the limitations of the present study was that although it showed changes in neuronal COX-2 abundance, it could not directly demonstrate the changes in neuronal COX activity. However, the demonstrated increases in oxidative DNA damage and microglial activation may also indirectly signal enhanced COX-2 activity these mechanisms indicate the development of a vicious cycle -mation triggered by microglial activation, and ROS-inflicted mitochondrial damage) lead to progressive neuronal injury. Molecular H 2 appears to interrupt this vicious cycle when applied immediately during the early reoxygenation phase after asphyxia.
We conclude that H 2 remains a promising neuroprotective agent to combat HIE development. H 2 -induced neuroprotection involves not only direct scavenging of ROS but also the inhibition of deleterious neuronal COX-2 induction in vulnerable neurons.
